Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» March 2012
March 2012
Bausch & Lomb to buy Ista Pharma in $500 mln deal
Bausch & Lomb to buy Ista Pharma in $500 mln deal
Marketwatch
M&A
ISTA Pharmaceuticals
Bausch & Lomb
ISTA Pharmaceuticals Gets The Bid It Wants
ISTA Pharmaceuticals Gets The Bid It Wants
Seeking Alpha
Vertex Pharmaceuticals
Novartis
ISTA Pharmaceuticals
Allergan
Bausch & Lomb
M&A
MAP Pharma shares dive after FDA rejects migraine drug
MAP Pharma shares dive after FDA rejects migraine drug
Reuters
FDA
migraines
MAP Pharmaceuticals
Abbott Laboratories Split Will Make The Perfect Team For Investors
Abbott Laboratories Split Will Make The Perfect Team For Investors
Seeking Alpha
Abbott Laboratories
investors
AbbVie
Is Pfizer Pfinished?
Is Pfizer Pfinished?
Seeking Alpha
Pfizer
Abbott Laboratories
JNJ
Will the FDA Approve Affymax's Peginesatide?
Will the FDA Approve Affymax's Peginesatide?
Motley Fool
FDA
Affymax
peginesatide
anemia
Ala. judge sets trial dates for suits over Chantix
Ala. judge sets trial dates for suits over Chantix
Yahoo/AP
Chantix
Alabama
Pfizer
J&J Goes Back To Texas Court Over Risperdal
J&J Goes Back To Texas Court Over Risperdal
Pharmalot
Texas
JNJ
Risperdal
Arena Pharma says EU is reviewing weight loss drug
Arena Pharma says EU is reviewing weight loss drug
Yahoo/AP
Arena
lorcaserin
Europe
obesity
Obesity Drugs May Need Heart Risk Studies Before Approval
Obesity Drugs May Need Heart Risk Studies Before Approval
Bloomberg
obesity
Vivus
Arena Pharmaceuticals
Orexigen
Qnexa
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »